🧪🧪 Highest laboratory safety - Novartis relies on Uepaa in the RLT laboratory
Headquartered in Basel, Novartis is one of the world's leading pharmaceutical companies. The company continuously invests in innovative therapies and state-of-the-art research facilities - including in the field of Radioligand Therapy (RLT). In highly specialized laboratories, scientists work daily to develop new treatment options for seriously ill patients.
Safety focus in the RLT laboratory, according to SUVA 44094:
Personalsafety is the top priority, especially when handling radioactive substances and highly sensitive processes. In the RLT laboratories at Novartis, this means clear structures, double checks - and a safety system that allows no compromises. Immediate alerting in the event of an emergency is essential, especially for activities that are carried out alone. This is exactly where Uepaa comes into play.
Direct connection to the internal alarm center:
TheUepaa lone worker app was integrated at Novartis in such a way that it is seamlessly connected to the internal alarm chain of the safety center. This means that in an emergency, an alarm is automatically forwarded to the relevant department without any loss of time. This direct connection not only offers maximum response speed, but also meets the strictest safety requirements.
- Automatic accident detection: The app automatically detects immobility or falls - without you having to take any action yourself.
- Dead man's switch: Regular activity checks require manual confirmation - if this is not received, an alarm is triggered immediately.
- Manual alarm: One push of a button is all it takes to call for help immediately in an emergency.
- Location transmission & connection: The exact position and direct connection to the internal alarm center ensure rapid intervention.
Conclusion- trust in technology and partnership: With the introduction of the Uepaa lone worker app, Novartis has taken another step towards proactive occupational safety - especially in one of the company's most sensitive work areas. We would like to thank them for their trust in our solution and look forward to further developing it together - for more safety in the research of tomorrow.
